ATS 2021

COVID-19: What Pulmonologists Need to Know

Antibody treatment for COVID-19: a combination is successful

Presented By

Dr Julie V. Philley, University of Texas Health Science Center, USA

Trial

REGN-COV 2067

Conference

ATS 2021

5 July, 2021 13:47

Air pollution: an underestimated negative prognostic factor for COVID-19

Presented By

Prof. Meredith McCormack, John Hopkins University, MD, USA

Conference

ATS 2021

5 July, 2021 13:46

Healthcare workers vulnerable to SARS-CoV-2 infections

Presented By

Prof. Reynold A. Panettieri Jr, Rutgers Institute for Translational Medicine and Science, NJ, USA

Conference

ATS 2021

5 July, 2021 13:46

Genetic risk variants responsible for COVID-19 predisposition

Presented By

Dr Ana Hernandez Cordero, Centre for Heart Lung Innovation, University of British Columbia, Canada

Conference

ATS 2021

5 July, 2021 13:46

Asthma – An Update

“As-needed” inhaled corticosteroid therapy for mild asthma – what is the evidence?

Presented By

Prof. Kaharu Sumino, Prof. Anne Dixon

Trial

SYGMA 1 and 2, PRACTICAL, START

Conference

ATS 2021

5 July, 2021 13:48

IL-4/13 blocker successful in treatment of paediatric moderate-to-severe asthma

Presented By

Prof. Leonhard B. Bacharier, Vanderbilt University Medical Center, TN, USA

Trial

VOYAGE

Conference

ATS 2021

5 July, 2021 13:48

Benralizumab lives up to its phase 3 results in real-world findings

Presented By

Dr Donna Carstens, AstraZeneca, Wilmington, DE, USA

Conference

ATS 2021

5 July, 2021 13:48

Tezepelumab – good success rates in various types of severe asthma

Presented By

Prof. Michael E. Wechsler, National Jewish Health, Denver, CO, USA

Trial

Phase 3, NAVIGATOR

Conference

ATS 2021

5 July, 2021 13:48

Sleep Disorders – An Underestimated Problem

OSA: A risk factor for earlier cognitive decline

Presented By

Prof. Andrew W. Varga, Mount Sinai Integrative Sleep Center, NY, USA

Conference

ATS 2021

5 July, 2021 13:49

Subgroup of patients with high heart rate response and coronary artery disease benefit from CPAP

Presented By

Prof. Ali Azarbarzin, Harvard Medical School, MA, USA

Trial

Phase 4, RICCADSA

Conference

ATS 2021

5 July, 2021 13:49

Association between positive airway pressure treatment adherence and COVID-19 infection rates

Presented By

Dr Dennis Hwang, Kaiser Permanente, CA, USA

Conference

ATS 2021

5 July, 2021 13:49

COPD – What Is New

Possible aetiologies for COPD exacerbations – more evidence is needed

Presented By

Prof. Surya P. Bhatt, Birmingham School of Medicine, AL, USA

Conference

ATS 2021

5 July, 2021 13:50

Does COPD plus COVID-19 equal higher mortality?

Presented By

Dr Jacob Schwartz, Lenox Hill Hospital, NY, USA

Conference

ATS 2021

5 July, 2021 13:50

Biomarkers for acute exacerbations in COPD are required

Presented By

Prof. Don D. Sin, University of British Columbia, BC, Canada

Conference

ATS 2021

5 July, 2021 13:50

Severe exacerbations: A key driver of all-cause mortality in COPD patients

Presented By

Prof. Manoj J. Mammen, Jacobs School of Medicine and Biomedical Sciences, NY, USA

Trial

Phase 3, IMPACT

Conference

ATS 2021

5 July, 2021 13:50

Men and women with COPD differ in many ways

Presented By

Dr Franziska Trudzinski, University Hospital Centre Heidelberg, Germany

Trial

Cohort study, cosyconet

Conference

ATS 2021

5 July, 2021 13:50

Younger adults with COPD at higher health risk than previously thought

Presented By

Dr Alina J. Blazer, University of Toronto, ON, Canada

Conference

ATS 2021

5 July, 2021 13:50

Metabolic Dysregulation and Lung Disease

Best of the Posters